Pixium Vision announces business update and key upcoming milestones to deliver on its business plan
Pixium Vision announces business update and key upcoming milestones to deliver on its business plan 1st patient successful implant activation in PRIMAvera pivotal EU studyOn track to report PRIMAvera data in early 2023 and submit CE mark in H1 2023Aims to capitalize on enhanced interest from US investorsOptions includes potential NASDAQ listing; US Investment bank hired Paris, France, June 2, 2021 – 07.00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronic...
Source: yahoo.com